![Breast cancer test could predict chances of disease's return 20 years later, study shows | The Independent | The Independent Breast cancer test could predict chances of disease's return 20 years later, study shows | The Independent | The Independent](https://static.independent.co.uk/s3fs-public/thumbnails/image/2018/05/02/22/pa-3649262.jpg)
Breast cancer test could predict chances of disease's return 20 years later, study shows | The Independent | The Independent
![A clinical calculator to predict disease outcomes in women with triple-negative breast cancer | SpringerLink A clinical calculator to predict disease outcomes in women with triple-negative breast cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-020-06030-5/MediaObjects/10549_2020_6030_Fig2_HTML.png)
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer | SpringerLink
Pulsus Journal of Surgical Research Using CTS5 Calculator to predict the 5-10 risk of recurrence and to reduce the number of pat
![Estimating long-term mortality in women with hormone receptor-positive breast cancer: The 'ESTIMATE' tool - ScienceDirect Estimating long-term mortality in women with hormone receptor-positive breast cancer: The 'ESTIMATE' tool - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S095980492200380X-gr1.jpg)
Estimating long-term mortality in women with hormone receptor-positive breast cancer: The 'ESTIMATE' tool - ScienceDirect
![Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia](https://www.mdpi.com/cancers/cancers-15-02064/article_deploy/html/images/cancers-15-02064-g001.png)
Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia
![Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer | Nature Reviews Clinical Oncology Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer | Nature Reviews Clinical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41571-018-0145-5/MediaObjects/41571_2018_145_Fig1_HTML.png)
Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer | Nature Reviews Clinical Oncology
![A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-61535-9/MediaObjects/41598_2020_61535_Fig3_HTML.png)
A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports
![Frontiers | Deep Learning-Based Prediction Model for Breast Cancer Recurrence Using Adjuvant Breast Cancer Cohort in Tertiary Cancer Center Registry Frontiers | Deep Learning-Based Prediction Model for Breast Cancer Recurrence Using Adjuvant Breast Cancer Cohort in Tertiary Cancer Center Registry](https://www.frontiersin.org/files/MyHome%20Article%20Library/596364/596364_Thumb_400.jpg)
Frontiers | Deep Learning-Based Prediction Model for Breast Cancer Recurrence Using Adjuvant Breast Cancer Cohort in Tertiary Cancer Center Registry
![Simple online calculator helps women determine their risk of breast cancer | The Independent | The Independent Simple online calculator helps women determine their risk of breast cancer | The Independent | The Independent](https://static.independent.co.uk/s3fs-public/thumbnails/image/2015/10/01/22/cancercalculator.gif)
Simple online calculator helps women determine their risk of breast cancer | The Independent | The Independent
![Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review](https://www.mdpi.com/cancers/cancers-14-01898/article_deploy/html/images/cancers-14-01898-g001.png)
Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review
![Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00288-8/MediaObjects/41523_2021_288_Fig1_HTML.png)
Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer
Cancer survival by stage at diagnosis for England (experimental statistics) - Office for National Statistics
![PDF) A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer PDF) A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer](https://i1.rgstatic.net/publication/272192765_A_preoperative_nomogram_to_predict_the_risk_of_synchronous_distant_metastases_at_diagnosis_of_primary_breast_cancer/links/574b5f0c08ae5c51e29ea959/largepreview.png)
PDF) A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer
![A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - ScienceDirect A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S096097762101002X-gr1.jpg)